ABVC BioPharma, Inc. Increase (Decrease) in Other Noncurrent Liabilities
ABVC BioPharma, Inc. (ABVC) reported Increase (Decrease) in Other Noncurrent Liabilities of -$1.08 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-31.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities · last filed 2022-03-31
- ABVC BioPharma, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2021-12-31 was $0.00.
- ABVC BioPharma, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2021-09-30 was $0.00.
- ABVC BioPharma, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2020-12-31 was -$1.35K.
- ABVC BioPharma, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2020-09-30 was -$504.00.
- ABVC BioPharma, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2021 was -$1.08K.
- ABVC BioPharma, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2020 was -$1.01K, a 153.17% decline from fiscal 2019.
- ABVC BioPharma, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2019 was $1.91K.
| Period end | Increase (Decrease) in Other Noncurrent Liabilities 3 month | Increase (Decrease) in Other Noncurrent Liabilities 6 month | Increase (Decrease) in Other Noncurrent Liabilities 9 month | Increase (Decrease) in Other Noncurrent Liabilities 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $0.00 derived: sum of 2 quarters · filed 2022-03-31 | -$1.08K 10-K · filed 2022-03-31 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$1.08K 10-Q · filed 2021-11-15 | ||
| 2021-06-30 | -$1.08K 10-Q · filed 2021-08-12 | |||
| 2020-12-31 | -$1.35K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$1.85K derived: sum of 2 quarters · filed 2022-03-31 | -$1.01K 10-K · filed 2022-03-31 | |
| 2020-09-30 | -$504.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $332.00 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | $836.00 10-Q · filed 2021-08-12 | |||
| 2019-12-31 | -$374.73K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $1.91K 10-K · filed 2021-03-16 | ||
| 2019-09-30 | $376.64K 10-Q · filed 2020-11-17 |